Related Experiment Video
Updated: Jan 5, 2026

Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation
Published on: August 19, 2020
Clinicopathological features and prognostic analysis of 49 cases with crescentic glomerulonephritis
Ting Wu1, Jiajia Peng1, Ting Meng1
1Department of Nephrology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China.
Insights
Crescentic glomerulonephritis (CrGN) subtypes show significant differences in kidney survival. Type I CrGN indicates the poorest kidney prognosis, while Type III CrGN offers superior kidney survival in rapidly progressive glomerulonephritis patients.
Area of Science:
- Nephrology
- Pathology
- Immunology
Background:
- Rapidly progressive glomerulonephritis (RPGN) is a severe kidney disease often linked to crescentic glomerulonephritis (CrGN).
- Understanding CrGN subtypes is crucial for predicting patient outcomes.
Purpose of the Study:
- To investigate the clinicopathological features of different CrGN types.
- To analyze the association between CrGN subtypes and patient prognosis.
Main Methods:
- Retrospective analysis of 49 patients with CrGN diagnosed via renal biopsy.
- Classification of CrGN into Type I, II, and III based on immunofluorescence and clinical data.
- Evaluation of kidney survival and overall patient survival rates.
Main Results:
- Prevalence: 22.45% Type I, 38.78% Type II, 38.78% Type III CrGN.
- Type I CrGN associated with higher acute kidney injury, elevated creatinine, and anti-GBM antibodies.
- Type III CrGN linked to anti-neutrophilic cytoplasmic autoantibodies.
- Type III CrGN showed superior kidney survival; Type I CrGN had the worst kidney prognosis (P<0.001).
- No significant difference in overall patient survival across types.
Conclusions:
- CrGN is a major cause of critical illness in RPGN.
- Significant heterogeneity exists among CrGN subtypes.
- Type I CrGN presents with acute onset and the poorest kidney survival, highlighting the need for tailored treatment strategies.
Abstract:
Rapidly progressive glomerulonephritis (RPGN), characterized by rapid kidney dysfunction caused by aggressive glomerulonephritis, is usually associated with crescentic glomerulonephritis (CrGN). In the present study, the data from patients with CrGN were retrospectively analyzed at a tertiary medical center in China with the aim of investigating the clinicopathological features and the association of the type of CrGN with the prognosis. The renal biopsies of 49 patients diagnosed with CrGN were obtained between December 2011 and July 2016. Of the 49 patients, 11 patients (22.45%) had type I CrGN, 19 (38.78%) had type II CrGN and 19 (38.78%) had type III CrGN. The majority of CrGN patients exhibited multiple-system involvement and 28 patients (57.14%) had kidney enlargement. Proportions of patients with acute kidney injury (AKI), acute kidney diseases without AKI, and chronic kidney disease were 28.57, 46.94 and 24.49%, respectively. Among the 3 types of CrGN, patients with type I CrGN tended to have a higher proportion of AKI with more cellular crescent formation, and higher serum creatinine and retinol binding protein. Circulating anti-GBM antibodies were present in all type I CrGN patients and anti-neutrophilic cytoplasmic autoantibodies were detected in 84.21% of patients with type III CrGN. Type III CrGN patients had a superior kidney survival, whereas type I CrGN patients had the worst kidney prognosis (P<0.001). There was no significant difference in overall patient survival among the 3 types of CrGN. CrGN remains the primary cause of critical illness in RPGN patients. There was much heterogeneity between the different subtypes of CrGN. Patients with type I tended to have an acute onset and had the poorest kidney survival.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations
Acute Pyelonephritis I: Introduction

